Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Discovery of molecular glues for modulating MHC presentation of cancer neoantigens

Created on 16 Nov 2026

Authors

Shen, W., Zhang, Z., He, C., Guiley, K. Z., Lashkari, V. D., Hernandez, J., Bruno, P. M., Shokat, K. M.

Abstract

Antigen presentation by MHC class I molecules is essential for cancer immunosurveillance, but many cancer-specific antigens fail to form complexes with Class I MHC and are poorly presented on the cell surface. In this study, we present a chemical strategy to overcome this limitation by identifying peptide MHC glues (PMGs) that promote the formation of peptide-MHC complexes with otherwise unpresentable cancer antigens. Crystal structures of these complexes show that our compounds stabilize antigen-MHC binding by making simultaneous interactions with the MHC protein and the antigen peptides. These findings reveal a new approach for chemically rewiring Class I MHC antigen presentation and accessing rare cancer antigens for therapeutic targeting.

Preprint server: bioRxiv
The authors list and abstract were imported from bioRxiv on 16 Nov 2026.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this preprint? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 14
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement